(11-((4-Hydroxy-3-methoxybenzoyl)oxy)undecyl)triphenylphosphonium bromide
Modify Date: 2024-01-21 13:26:11
(11-((4-Hydroxy-3-methoxybenzoyl)oxy)undecyl)triphenylphosphonium bromide structure
|
Common Name | (11-((4-Hydroxy-3-methoxybenzoyl)oxy)undecyl)triphenylphosphonium bromide | ||
|---|---|---|---|---|
| CAS Number | 1254044-38-6 | Molecular Weight | 663.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C37H44BrO4P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (11-((4-Hydroxy-3-methoxybenzoyl)oxy)undecyl)triphenylphosphonium bromideMito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP+ cation. Mito-apocynin (C11) selectively targets mitochondria, and shows neuroprotective effect. Mito-apocynin (C11) prevents hyposmia and corrects deficits in motor function[1]. |
| Name | Mito-apocynin (C11) |
|---|
| Description | Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP+ cation. Mito-apocynin (C11) selectively targets mitochondria, and shows neuroprotective effect. Mito-apocynin (C11) prevents hyposmia and corrects deficits in motor function[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Mito-apocynin-C11 (3 mg/kg; oral gavage; 3x/wk from 3 months of age until 15 months) markedly improves the coordinated motor function and olfactory function in LRRK2R1441G mice[1]. Animal Model: LRRK2R1441G mice[1] Dosage: 3 mg/kg Administration: Oral gavage; 3x/wk from 3 months of age until 15 months Result: Markedly improved the coordinated motor function and olfactory function. |
| References |
| Molecular Formula | C37H44BrO4P |
|---|---|
| Molecular Weight | 663.62 |
| Hazard Codes | Xn |
|---|